| Literature DB >> 35326287 |
Piotr Macek1, Małgorzata Poręba1,2, Aneta Stachurska1, Helena Martynowicz1, Grzegorz Mazur1, Paweł Gać3, Rafał Poręba1.
Abstract
Our study aimed to assess functional, structural changes of the right ventricular using strain parameters and sleep structure using polysomnography in patients with obstructive sleep apnea (OSA). Our study group consisted of 43 patients, 29 men, 14 women. The mean age was 56.36 ± 14.77. All patients underwent full night polysomnography and transthoracic echocardiography. The right ventricular global longitudinal strain was measured by 2D speckle-tracking echocardiography. The prevalence of OSA (AHI ≥ 5) was 76.7% in the studied group. We observed a significant positive correlation between OAH and average free wall strain (r = 0.37), snore and mid-free wall strain (r = 0.34), average HR, and basal free wall strain (r = 0.34). Moreover, CSB was positively correlated with basal septal strain and mid septal strain (r = 0.36 and 0.42). In summary, among patients with sleep disorders, functional disorders of the right ventricle, assessed using the strain method, are partly observed.Entities:
Keywords: obstructive sleep apnea; right ventricle; sleep structure; strain
Year: 2022 PMID: 35326287 PMCID: PMC8946732 DOI: 10.3390/brainsci12030331
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Clinical characteristics of the study group.
| X | Me | SD | Min | Max | |
|---|---|---|---|---|---|
| Age [years] | 56.36 | 59.50 | 14.77 | 23.00 | 81.00 |
| Height [cm] | 172.67 | 173.00 | 8.96 | 158.00 | 188.00 |
| Body mass [kg] | 80.27 | 82.00 | 19.04 | 53.00 | 125.00 |
| Body mass index [kg/m2] | 26.71 | 25.75 | 4.90 | 19.95 | 36.13 |
| n | % | ||||
| Age < 60 | 21 | 48.8 | |||
| Age ≥ 60 | 22 | 51.2 | |||
| Men | 29 | 67.4 | |||
| Women | 14 | 32.5 | |||
| Normal body mass | 26 | 60.5 | |||
| Overweight/obesity | 17 | 39.5 | |||
| Arterial hypertension | 26 | 60.5 | |||
| Coronary artery diseases | 4 | 9.3 | |||
| Type 2 diabetes | 5 | 11.6 | |||
Polysomnography parameters in the study group.
| X | Me | SD | Min | Max | |
|---|---|---|---|---|---|
| AHI [events/hours] | 27.09 | 23.05 | 19.76 | 0.20 | 71.30 |
| ODI [events/hours] | 27.44 | 26.30 | 19.74 | 0.20 | 73.70 |
| Snore [events/hours] | 23.43 | 11.40 | 24.93 | 0.00 | 81.60 |
| OAH [events/hours] | 6.84 | 1.70 | 10.30 | 0.00 | 38.40 |
| CAH [events/hours] | 0.80 | 0.15 | 1.66 | 0.00 | 9.10 |
| CSB [events/hours] | 1.60 | 0.00 | 4.09 | 0.00 | 19.90 |
| Average SpO2 [%] | 91.42 | 92.20 | 4.75 | 65.50 | 96.10 |
| Minimal SpO2 [%] | 80.90 | 82.00 | 7.45 | 64.00 | 94.00 |
| % SpO2 < 90 [%] | 14.75 | 5.30 | 21.29 | 0.00 | 91.00 |
| Average desaturation [%] | 6.48 | 4.50 | 11.51 | 2.00 | 77.00 |
| Average HR [bpm] | 61.63 | 61.85 | 8.16 | 45.80 | 80.00 |
| Minimal HR [bpm] | 49.33 | 50.00 | 9.31 | 24.00 | 69.00 |
| Maximal HR [bpm] | 89.85 | 89.50 | 15.65 | 62.00 | 141.00 |
| Sleep efficiency [%] | 78.16 | 81.25 | 14.55 | 25.30 | 93.60 |
| TST N1 [% sleep time] | 8.52 | 4.50 | 8.24 | 0.60 | 33.90 |
| TST N2 [% sleep time] | 54.94 | 51.60 | 27.62 | 24.40 | 98.00 |
| TST N3 [% sleep time] | 21.74 | 19.35 | 13.31 | 1.20 | 61.50 |
| TST REM [% sleep time] | 25.35 | 21.40 | 19.28 | 2.90 | 98.50 |
| n | % | ||||
| AHI < 5 (without OSA) | 10 | 23.3 | |||
| AHI ≥ 5 (OSA) | 33 | 76.7 | |||
| AHI: 5–15 (mild OSA) | 4 | 9.3 | |||
| AHI: 15–30 (moderate OSA) | 15 | 34.9 | |||
| AHI ≥ 30 (severe OSA) | 14 | 32.5 | |||
AHI, apnea–hypopnea index; ODI, oxygen desaturation index; OAH, obstructive apneas events; CAH, central apneas events; CSB, Cheyne-Stokes breathing; SpO2, saturation; HR, heart rate; TST, total sleep time (min); N1, sleep stage 1; N2, sleep stage 2; N3, sleep stage 3; REM, rapid eye movement sleep stage; OSA, obstructive sleep apnea.
Right ventricular echocardiography parameters in the study group.
| X | Me | SD | Min | Max | |
|---|---|---|---|---|---|
| RAA [cm2] | 25.02 | 24.75 | 1.13 | 24.00 | 26.70 |
| RA major dimension [mm] | 49.40 | 44.00 | 17.64 | 24.00 | 92.00 |
| RA minor dimension [mm] | 47.60 | 43.00 | 15.93 | 23.00 | 84.00 |
| RVOT p [mm] | 31.58 | 32.00 | 4.33 | 18.00 | 40.00 |
| RVOT m [mm] | 32.86 | 33.50 | 4.45 | 22.00 | 41.00 |
| RVOT d [mm] | 27.80 | 27.00 | 4.03 | 21.00 | 37.00 |
| MPA [mm] | 26.11 | 25.00 | 1.90 | 24.00 | 29.00 |
| RVD [mm] | 36.95 | 37.00 | 4.26 | 29.00 | 51.00 |
| s’RV [cm/s] | 13.63 | 13.00 | 2.46 | 10.00 | 20.00 |
| TAPSE [mm] | 24.51 | 24.00 | 3.60 | 19.00 | 34.00 |
| RV E [cm/s] | 60.58 | 60.50 | 11.67 | 39.00 | 92.00 |
| RV A [cm/s] | 51.79 | 47.50 | 15.74 | 28.00 | 109.00 |
| RV E/A | 1.00 | 0.91 | 0.30 | 0.71 | 1.68 |
| RVEDt [ms] | 254.42 | 242.00 | 64.75 | 118.00 | 405.00 |
| RV E’ [cm/s] | 10.00 | 9.00 | 3.70 | 4.00 | 24.00 |
| RV A’ [cm/s] | 12.90 | 13.00 | 3.45 | 5.00 | 21.00 |
| TCO [ms] | 393.40 | 377.00 | 47.05 | 319.00 | 494.00 |
| RVET [ms] | 300.93 | 303.00 | 27.84 | 247.00 | 354.00 |
| RIMP | 0.71 | 0.71 | 0.15 | 0.60 | 0.81 |
| PAV [cm/s] | 74.35 | 73.00 | 9.88 | 55.00 | 104.00 |
| PAAT [ms] | 140.93 | 145.00 | 26.12 | 88.00 | 198.00 |
RAA, right atrial area; RA, right atrial; RVOT p, proximal right ventricular outflow diameter; RVOT m, mid right ventricular outflow diameter; RVOT d, distal right ventricular outflow diameter; MPA, main pulmonary artery diameter; RVD, basal right ventricle diameter; s’RV, peak systolic velocity of tricuspid annulus by pulsed wave Tissue Doppler Imaging; TAPSE, tricuspid annular plane systolic excursion; RV E, early peak transtricuspid diastolic flow; RV A, late peak transtricuspidal diastolic flow; RV E/A, ratio of early to late peak transtricuspid diastolic flow; RVEDt, deceleration time of early peak transtricuspid diastolic flow; RV E’, early peak diastolic velocity of tricuspid annulus by pulsed wave Tissue Doppler Imaging; RV A’, late peak diastolic velocity of tricuspid annulus by pulsed wave Tissue Doppler Imaging; TCO, tricuspid valve closure opening time; RVET, right ventricular ejection time; RIMP, right ventricular myocardial performance index; PAFV, peak of pulmonary artery flow velocity; PAAT, pulmonary artery acceleration time
Right ventricular strain parameters in the study group.
| X | Me | SD | Min | Max | |
|---|---|---|---|---|---|
| Average free wall strain [%] | −27.83 | −27.00 | 5.81 | −42.00 | −17.50 |
| Basal free wall strain [%] | −27.19 | −26.00 | 6.10 | −45.00 | −15.00 |
| Mid free wall strain [%] | −28.88 | −28.00 | 5.67 | −44.00 | −20.00 |
| Apex free wall strain [%] | −23.67 | −23.00 | 6.56 | −36.00 | −8.00 |
| Average septal strain [%] | −16.58 | −17.00 | 4.41 | −25.00 | −6.67 |
| Basal septal strain [%] | −16.47 | −17.00 | 4.73 | −26.00 | −5.00 |
| Mid septal strain [%] | −17.02 | −17.00 | 4.72 | −26.00 | −4.00 |
| Apex septal strain [%] | −16.26 | −15.00 | 5.60 | −29.00 | −4.00 |
Right ventricular strain parameters in subgroups separated based on OSA (statistically significant differences between the groups were bolded).
| AHI < 5 (without OSA) | AHI ≥ 5 (OSA) | ||||
|---|---|---|---|---|---|
| X | SD | X | SD | ||
|
|
|
|
|
| |
| Basal free wall strain [%] | −31.57 | 7.46 | −26.58 | 5.67 | 0.052 |
|
|
|
|
|
| |
| Apex free wall strain [%] | −26.71 | 8.73 | −23.03 | 6.23 | 0.194 |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Correlations between polysomnography parameters and right ventricular strain parameters in whole study group (the statistically significant correlation coefficients were bolded).
| Average Free Wall Strain | Basal Free Wall Strain | Mid Free Wall Strain | Apex Free Wall Strain | Average Septal Strain | Basal Septal Strain | Mid Septal Strain | Apex Septal Strain | |
|---|---|---|---|---|---|---|---|---|
| AHI [events/hours] | 0.20 | 0.08 | 0.26 | 0.07 | −0.01 | 0.02 | −0.01 | −0.04 |
| ODI [events/hours] | 0.16 | 0.04 | 0.22 | 0.07 | 0.05 | 0.10 | 0.06 | −0.02 |
| Snore [events/hours] | 0.19 | 0.09 |
| 0.15 | 0.03 | 0.12 | 0.00 | −0.03 |
| OAH [events/hours] |
| 0.21 | 0.30 | 0.11 | −0.06 | −0.17 | −0.07 | 0.05 |
| CAH [events/hours] | 0.17 | 0.18 | 0.15 | −0.01 | 0.14 | 0.26 | 0.24 | −0.08 |
| CSB [events/hours] | −0.01 | −0.09 | 0.07 | 0.11 | 0.33 |
|
| 0.15 |
| Average SpO2 [%] | −0.28 | −0.23 | −0.22 | −0.14 | 0.07 | 0.10 | 0.11 | 0.00 |
| Minimal SpO2 [%] | −0.08 | −0.01 | −0.16 | −0.20 | −0.14 | −0.12 | −0.12 | −0.12 |
| % SpO2 < 90 [%] | 0.17 | 0.08 | 0.24 | 0.19 | 0.12 | 0.15 | 0.12 | 0.06 |
| Average desaturation [%] | 0.11 | 0.10 | 0.12 | −0.06 | −0.07 | −0.07 | −0.01 | −0.11 |
| Average HR [bpm] | 0.26 |
| 0.20 | −0.10 | 0.17 | 0.22 | 0.16 | 0.09 |
| Minimal HR [bpm] | 0.08 | 0.13 | 0.02 | −0.18 | 0.02 | 0.06 | 0.01 | −0.00 |
| Maximal HR [bpm] | 0.25 | 0.24 | 0.10 | 0.03 | 0.19 | 0.12 | 0.17 | 0.20 |
| Sleep efficiency [%] | −0.22 | −0.21 | −0.25 | −0.14 | −0.09 | −0.07 | −0.01 | −0.15 |
| TST N1 [% sleep time] | 0.20 | 0.19 | 0.16 | 0.07 | 0.02 | −0.07 | 0.01 | 0.10 |
| TST N2 [% sleep time] | −0.01 | 0.02 | −0.02 | −0.04 | 0.01 | 0.05 | 0.02 | −0.03 |
| TST N3 [% sleep time] | 0.02 | −0.01 | 0.10 | 0.11 | −0.00 | 0.05 | −0.02 | −0.03 |
| TST REM [% sleep time] | 0.21 | 0.07 | 0.02 | −0.07 | 0.07 | 0.12 | 0.12 | −0.01 |
AHI, apnea–hypopnea index; ODI, oxygen desaturation index; OAH, obstructive apneas events; CAH, central apneas events; CSB, Cheyne-Stokes breathing; SpO2, saturation; HR, heart rate; TST, total sleep time (min); N1, sleep stage 1; N2, sleep stage 2; N3, sleep stage 3; REM, rapid eye movement sleep stage; OSA, obstructive sleep apnea.
Figure 1Correlation between AHI and RV mid free wall strain in the study subgroup with age below 60 years (red solid line—estimation curve, dashed lines—95% confidence interval of the estimation curve, small blue circles—individual cases).
Figure 2Correlation between AHI and RV basal septal strain in women subgroup (red solid line—estimation curve, dashed lines—95% confidence interval of the estimation curve, small blue circles—individual cases).